Literature DB >> 27671828

Morin and Its Role in Chronic Diseases.

Krishnendu Sinha1,2, Jyotirmoy Ghosh3, Parames C Sil4.   

Abstract

Chronic diseases can be referred to the long-term medical conditions which are mostly progressive in nature, i.e., it deteriorates over time. Diabetes, arthritis, heart disease, stroke, cancer, and chronic respiratory problems (e.g., COPD) are not a few examples of chronic diseases and chronic diseases are the leading causes of death and disability all over the world. Chronic diseases and conditions are among the most common, costly, and preventable of all health problems. Affordable cost, presence mostly in the consumables, and minimal side effects make the naturally occurring compounds interesting and attractive for pharmacological study in recent years. Plants produce diverse types of low molecular weight products mainly for the defense purpose. Among them, the group of secondary metabolites related to a polyphenolic group has been named flavonoids and are of great interest due to their incredible pharmacological properties. In these regard, due to its potent anti-inflammatory, anti-apoptotic and many important pharmacological properties (relevant to chronic diseases, e.g., urate transporter inhibitor related to gout, modulator of immunosystem related to chronic hypersensitivity, etc.), morin [morin hydrate:2-(2,4-dihydroxyphenyl)-3,5,7-trihydroxy-4H-1-benzopy ran-4-one; 3,5,7,20,40 pentahydroxyflavone], widely found among the Moraceae family, considered as one of the most important key bioflavonols. However, little is known about the molecular mechanisms of its action on such conditions. In this chapter, we have summarized most of the findings, if not all, available till date.

Entities:  

Keywords:  Anti-inflammatory; Antioxidant; Cellular signaling; Chronic diseases; Morin

Mesh:

Substances:

Year:  2016        PMID: 27671828     DOI: 10.1007/978-3-319-41334-1_19

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  8 in total

1.  Morin, a novel liver X receptor α/β dual antagonist, has potent therapeutic efficacy for nonalcoholic fatty liver diseases.

Authors:  Ming Gu; Yu Zhang; Chuhe Liu; Dongshan Wang; Li Feng; Shengjie Fan; Baican Yang; Qingchun Tong; Guang Ji; Cheng Huang
Journal:  Br J Pharmacol       Date:  2017-08-11       Impact factor: 8.739

2.  Morin Inhibits Dox-Induced Vascular Inflammation By Regulating PTEN/AKT/NF-κB Pathway.

Authors:  Jing Yu; Hai-Liang Qi; Hong Zhang; Zi-Yu Zhao; Zi-Yuan Nie
Journal:  Inflammation       Date:  2022-06-15       Impact factor: 4.092

3.  The Interaction of Flavonols with Membrane Components: Potential Effect on Antioxidant Activity.

Authors:  Sarmistha Saha; Emiliano Panieri; Sibel Suzen; Luciano Saso
Journal:  J Membr Biol       Date:  2020-01-02       Impact factor: 1.843

Review 4.  Polyphenols with Anti-Amyloid β Aggregation Show Potential Risk of Toxicity Via Pro-Oxidant Properties.

Authors:  Hatasu Kobayashi; Mariko Murata; Shosuke Kawanishi; Shinji Oikawa
Journal:  Int J Mol Sci       Date:  2020-05-18       Impact factor: 5.923

Review 5.  A Review of Traditional Chinese Medicine in Treating Renal Interstitial Fibrosis via Endoplasmic Reticulum Stress-Mediated Apoptosis.

Authors:  Yu Liu; Dan-Qian Chen; Jing-Xue Han; Ting-Ting Zhao; Shu-Ju Li
Journal:  Biomed Res Int       Date:  2021-05-15       Impact factor: 3.246

Review 6.  Traditional Chinese herbs and natural products in hyperuricemia-induced chronic kidney disease.

Authors:  Letian Yang; Bo Wang; Liang Ma; Ping Fu
Journal:  Front Pharmacol       Date:  2022-08-09       Impact factor: 5.988

7.  Model yeast as a versatile tool to examine the antioxidant and anti-ageing potential of flavonoids, extracted from medicinal plants.

Authors:  Hira Zahoor; Kwanrutai Watchaputi; Janejira Hata; Wachirachai Pabuprapap; Apichart Suksamrarn; Lee Suan Chua; Nitnipa Soontorngun
Journal:  Front Pharmacol       Date:  2022-09-02       Impact factor: 5.988

8.  Preparation, characterization and systemic application of self-assembled hydroxyethyl starch nanoparticles-loaded flavonoid Morin for hyperuricemia therapy.

Authors:  Jianbo Li; Yang Yang; Likang Lu; Qiujin Ma; Jinjie Zhang
Journal:  Int J Nanomedicine       Date:  2018-04-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.